.png){kind=icon}
返回
Targeting immune dysfunction in aging
.png){kind=icon}
OA
AI
DOI：10.1016/j.arr.2021.101410.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Human aging is a multifactorial phenomenon that affects numerous organ systems and cellular processes, with the immune system being one of the most dysregulated. Immunosenescence, the gradual deterioration of the immune system, and inflammaging, a chronic inflammatory state that persists in the elderly, are among the plethora of immune changes that occur during aging. Almost all populations of immune cells change with age in terms of numbers and/or activity. These alterations are in general highly detrimental, resulting in an increased susceptibility to infections, reduced healing abilities, and altered homeostasis that promote the emergence of age-associated diseases such as cancer, diabetes, and other diseases associated with inflammation. Thanks to recent developments, several strategies have been proposed to target central immunological processes or specific immune subpopulations affected by aging. These therapeutic approaches could soon be applied in the clinic to slow down or even reverse specific age-induced immune changes in order to rejuvenate the immune system and prevent or reduce the impact of various diseases. Due to its systemic nature and interconnection with all the other systems in the body, the immune system is an attractive target for aging intervention because relatively targeted modifications to a small set of cells have the potential to improve the health of multiple organ systems. Therefore, anti-aging immune targeting therapies could represent a potent approach for improving healthspan. Here, we review aging changes in the major components of the immune system, we summarize the current immune-targeting therapeutic approaches in the context of aging and discuss the future directions in the field of immune rejuvenation.
Keyword:
Healthy longevity
Geroscience
Inflammation
Immune system
Anti-aging
Immunosenescence
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
12.4
论文数:
3.6K
被引数:
3.1W
机构
引用论文
Antitumor Activity of ZD6474, a Vascular Endothelial Growth Factor-2 and Epidermal Growth Factor Receptor Small Molecule Tyrosine Kinase Inhibitor, in Combination with SC-236, a Cyclooxygenase-2 Inhibitor血管内皮生长因子-2和表皮生长因子受体小分子酪氨酸激酶抑制剂ZD6474与cyclooxygenase-2抑制剂SC-236联用的抗肿瘤活性
OAAI
OAAI分享收藏A novel distance measurement technique for indoor positioning systems based on Zadoff-Chu Sequences
PREAI
分享收藏Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity.png)
JGH OpenOAAI
JGH OpenIF0
OAAI分享收藏Dendritic cells: Bridging innate and adaptive immunity in atopic dermatitis树突状细胞: 在特应性皮炎中桥接先天性和适应性免疫
PREAI
分享收藏Polyamines Control eIF5A Hypusination, TFEB Translation, and Autophagy to Reverse B Cell Senescence多胺控制eIF5A的Hypusination，TFEB翻译和自噬以逆转b细胞衰老MOLECULAR CELLOAAI
MOLECULAR CELLIF16.6
OAAI分享收藏SARS-CoV-2, immunosenescence and inflammaging: partners in the COVID-19 crimeSARS-CoV-2，免疫衰老和发炎: 新型冠状病毒肺炎犯罪的伙伴AGING-USOAAI
AGING-USIF3.9
OAAI分享收藏
查看更多内容